Fe3 Medical Secures $11,000,000 Series B Financing

  • Feed Type
  • Date
    3/3/2016
  • Company Name
    Fe3 Medical
  • Mailing Address
    12500 Network Blvd. San Antonio, TX 78249 USA
  • Company Description
    Fe3 is an early stage company developing a novel transdermal therapy for the treatment of iron deficiency anemia. The approach and technology for Fe3 was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations.
  • Website
    http://www.fe3medical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will be used for clinical trials and regulatory submissions required to obtain CE Mark and FDA approval for the transdermal patch.
  • M&A Terms
  • Venture Investor
    Jianmin Pharmaceuticals
  • Venture Investor
    HG Capital
  • Venture Investor
    Ping An Group
  • Venture Investor
    Undisclosed